Dr. Jonathan Coleman, MD, Memorial Sloan Kettering Cancer Research Center, and Prof. Avigdor Scherz, Weizmann Institute of Science, discuss ongoing clinical trials at MSKCC testing vascular targeted photodynamic therapy for prostate cancer. Developed at the Weizmann Institute, this revolutionary treatment uses light emitted by optical fibers that are inserted into the prostate (and possibly other areas), activating a drug that destroys cancer cells—with little side effects.
Fighting Cancer
Revolutionary Advances in Cancer Treatment: Memorial Sloan Kettering Cancer Center and the Weizmann Institute of Science
-
Make a donation and help Weizmann scientists pursue a better tomorrow.
Donate
